Our clinical case digest brings together the vast and varied peer discussions of our Myopia Profile Facebook group into valuable, enduring content with the addition of key learnings, relevant research and engaging graphics. Seeing the research put into practice, in real patient cases, will help you elevate your myopia management knowledge and confidence to higher levels.
Getting the most out of Myopia Profile Welcome to the world’s largest and most popular multi-platform digital suite dedicated to myopia management! Perhaps you’re new to the Myopia Profile website,… This hospital-based study of high myopes aged 12 to 47 years found that myopia-related retinal pathologies were common, especially with more than 8D of myopia, greater than 26.5mm axial length and longer durations of myopia. Age and family history were not associated with retinal pathology – highlighting the need for close retinal health monitoring in high myopes of all ages. In our Q&A interview format, we talk to Mario Teufl, optometrist from Austria, who explains how he uses the Topcon MYAH in his practice for myopia management – from axial length to topography to dry eye and more. Our Q&A format explores new technologies, products and research with experts. In this interview, Dr Sherman Tung, optometrist from Canada, shares his experience with The SightGlass Vision DOT 0.2 Lens in his practice, from prescribing to parent explanations and clinical outcomes. Peripheral vision function and reading speed were unaffected by highly aspherical (HAL) and slightly aspherical lenslet (SAL) spectacle lens designs compared to single vision lenses. Low contrast acuity was slightly reduced through the lenslet zone. In this case, a colleague has his first experience with the new Essilor Stellest spectacle lens for childhood myopia, with discussion including when to change the prescription and when to stop treatment. This study evaluated the visual performance and optical quality of three lenslet design spectacle lenses. While all degraded visual performance in some capacity, the concentric design (highly and slightly aspherical) lenses generally had a significantly lower impact on both acuity and contrast than honeycomb configuration (HC). Spectacle lenses which effectively control myopia progression are the next phase in widespread uptake of myopia management. Learn more about the Essilor Stellest lens, from myopia control to vision and visual function outcomes. Two prototype myopia control soft contact lens designs with non-coaxial optics showed enhanced efficacy in one design and enhanced vision in the other, compared to dual-focus and single-vision designs. This initial data is for six months, and all myopia control contact lens designs showed close to 6/6 or 20/20 acuity equivalent. This study demonstrated that man-made indoor environments may provide a myopigenic effect from reduced illumination and spatial frequencies. More research is needed to confirm if the mechanism for form deprivation from reduced spatial frequencies in humans is similar to that found for animals, and what improvements can be made to indoor environments to offset the risk for myopia. This Singapore study found that 10-12% of ALL adult myopes aged 40-80 years – not just high myopes – suffered either onset or progression of MMD over 12 years. Risk factors included each additional year of age and 1mm of axial length. The most significant predictive sign was tesselated fundus. How to Use Myopia Profile
Retinal pathology is common in younger people with high myopia
The Topcon MYAH – Q&A with Mario Teufl
The SightGlass DOT Lens – Q&A with Dr Sherman Tung
Is peripheral vision and reading speed affected by aspherical lenslet spectacle lenses?
A successful spectacle lens fitting for myopia
How do different lenslet configurations in myopia control spectacle lenses influence visual performance?
Understanding the new Essilor Stellest spectacle lens
A novel ring-focus soft contact lens design for myopia control
How could man-made environments influence childhood development of myopia?
Frequency and prediction of myopic macular degeneration in adults
